Share-based Payment Arrangement, Expense in USD of Tvardi Therapeutics, Inc. from 2012 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Tvardi Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and change rate from 2012 to Q3 2025.
  • Tvardi Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $339K, a 324% increase year-over-year.
  • Tvardi Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2019 was $10.3M, a 22.6% increase from 2018.
  • Tvardi Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2018 was $8.4M, a 32.7% increase from 2017.
  • Tvardi Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2017 was $6.33M, a 126% increase from 2016.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Tvardi Therapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $339K +$259K +324% 01 Jul 2025 30 Sep 2025 10-Q 13 Nov 2025
Q2 2025 $627K +$548K +694% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025
Q3 2024 $80K 01 Jul 2024 30 Sep 2024 10-Q 13 Nov 2025
Q2 2024 $79K 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025
Q2 2021 $3.03M +$218K +7.75% 01 Apr 2021 30 Jun 2021 10-Q 09 Aug 2021
Q1 2021 $2.6M -$75K -2.8% 01 Jan 2021 31 Mar 2021 10-Q 10 May 2021
Q3 2020 $11.2M $3.03M +$316K +11.6% 01 Jul 2020 30 Sep 2020 10-Q 09 Nov 2020
Q2 2020 $10.9M $2.81M +$131K +4.89% 01 Apr 2020 30 Jun 2020 10-Q 09 Aug 2021
Q1 2020 $10.7M $2.68M +$445K +19.9% 01 Jan 2020 31 Mar 2020 10-Q 10 May 2021
Q4 2019 $10.3M $2.67M +$30K +1.14% 01 Oct 2019 31 Dec 2019 10-K 27 Feb 2020
Q3 2019 $10.3M $2.71M +$894K +49.1% 01 Jul 2019 30 Sep 2019 10-Q 09 Nov 2020
Q2 2019 $9.38M $2.68M +$612K +29.6% 01 Apr 2019 30 Jun 2019 10-Q 10 Aug 2020
Q1 2019 $8.76M $2.23M +$363K +19.4% 01 Jan 2019 31 Mar 2019 10-Q 11 May 2020
Q4 2018 $8.4M $2.64M 01 Oct 2018 31 Dec 2018 10-K 27 Feb 2020
Q3 2018 $1.82M -$275K -13.1% 01 Jul 2018 30 Sep 2018 10-Q 05 Nov 2019
Q2 2018 $2.07M 01 Apr 2018 30 Jun 2018 10-Q 07 Aug 2019
Q1 2018 $1.87M 01 Jan 2018 31 Mar 2018 10-Q 07 May 2019
Q3 2017 $2.09M 01 Jul 2017 30 Sep 2017 10-Q 06 Nov 2018
Q3 2014 $222K +$163K +276% 01 Jul 2014 30 Sep 2014 10-Q 10 Nov 2014
Q2 2014 $456K +$416K +1040% 01 Apr 2014 30 Jun 2014 10-Q 07 Aug 2014
Q3 2013 $59K 01 Jul 2013 30 Sep 2013 10-Q 10 Nov 2014
Q2 2013 $40K 01 Apr 2013 30 Jun 2013 10-Q 07 Aug 2014

Tvardi Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2019 $10.3M +$1.9M +22.6% 01 Jan 2019 31 Dec 2019 10-K 27 Feb 2020
2018 $8.4M +$2.07M +32.7% 01 Jan 2018 31 Dec 2018 10-K 27 Feb 2020
2017 $6.33M +$3.53M +126% 01 Jan 2017 31 Dec 2017 10-K 27 Feb 2020
2016 $2.8M 01 Jan 2016 31 Dec 2016 10-K 12 Mar 2019
2014 $1.37M +$1.25M +1015% 01 Jan 2014 31 Dec 2014 10-K 27 Mar 2015
2013 $123K +$62K +102% 01 Jan 2013 31 Dec 2013 10-K 27 Mar 2015
2012 $61K 01 Jan 2012 31 Dec 2012 10-K 27 Mar 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.